Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Illumina, Inc. (ILMN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Illumina, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1110803.
Total stock buying since 2005: $2,748,194.
Total stock sales since 2005: $1,191,574,365.
Total stock option exercises since 2005: $187,225,090.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 18,450 | $1,500,027 | 0 | $0 | 0 | $0 |
| 2024 | 7,330 | $996,344 | 0 | $0 | 0 | $0 |
| 2023 | 0 | $0 | 11,630 | $2,288,888 | 68,902 | $540,284 |
| 2022 | 0 | $0 | 6,787 | $2,313,640 | 38,110 | $0 |
| 2021 | 0 | $0 | 76,862 | $32,133,367 | 53,748 | $0 |
| 2020 | 0 | $0 | 153,063 | $51,235,027 | 107,230 | $0 |
| 2019 | 0 | $0 | 166,043 | $51,488,681 | 148,450 | $4,489,250 |
| 2018 | 0 | $0 | 207,105 | $59,766,035 | 152,950 | $3,491,285 |
| 2017 | 0 | $0 | 455,648 | $88,829,978 | 425,871 | $21,632,278 |
| 2016 | 0 | $0 | 304,789 | $48,921,636 | 545,401 | $8,014,616 |
| 2015 | 0 | $0 | 1,117,701 | $221,793,291 | 753,395 | $24,718,407 |
| 2014 | 0 | $0 | 1,302,250 | $215,660,563 | 1,262,640 | $37,615,935 |
| 2013 | 0 | $0 | 1,596,048 | $118,377,128 | 1,492,387 | $40,207,436 |
| 2012 | 1,217 | $47,458 | 186,591 | $9,547,988 | 206,000 | $3,823,781 |
| 2011 | 4,839 | $204,365 | 793,264 | $55,004,833 | 780,467 | $11,494,144 |
| 2010 | 0 | $0 | 1,462,467 | $65,282,978 | 1,178,143 | $16,880,360 |
| 2009 | 0 | $0 | 948,051 | $34,070,305 | 524,296 | $4,030,889 |
| 2008 | 0 | $0 | 999,177 | $62,564,210 | 426,200 | $4,917,923 |
| 2007 | 0 | $0 | 1,065,401 | $47,966,087 | 533,039 | $5,235,340 |
| 2006 | 0 | $0 | 553,233 | $17,611,673 | 28,700 | $133,162 |
| 2005 | 0 | $0 | 546,352 | $6,718,057 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-03-06 | Ronaghi Mostafa (Sr VP & CTO) | Sale | 10,000 | 179.23 | 1,792,330 |
| 2014-03-06 | Ronaghi Mostafa (Sr VP & CTO) | Option Ex | 10,000 | 44.38 | 443,800 |
| 2014-03-06 | Bradbury Daniel (Director) | Sale | 2,100 | 175.32 | 368,182 |
| 2014-03-06 | Bradbury Daniel (Director) | Option Ex | 2,100 | 39.14 | 82,194 |
| 2014-03-03 | Bouchard Michel (Chief Accounting Officer) | Sale | 631 | 170.24 | 107,423 |
| 2014-03-03 | Bouchard Michel (Chief Accounting Officer) | Option Ex | 631 | 69.34 | 43,753 |
| 2014-02-28 | Bouchard Michel (Chief Accounting Officer) | Sale | 2,363 | 178.56 | 421,937 |
| 2014-02-28 | Bouchard Michel (Chief Accounting Officer) | Option Ex | 2,363 | 37.04 | 87,525 |
| 2014-02-27 | Flatley Jay T (CEO) | Sale | 30,000 | 179.39 | 5,381,580 |
| 2014-02-27 | Flatley Jay T (CEO) | Option Ex | 30,000 | 20.04 | 601,200 |
| 2014-02-25 | Bouchard Michel (Chief Accounting Officer) | Sale | 24,505 | 177.12 | 4,340,276 |
| 2014-02-25 | Bouchard Michel (Chief Accounting Officer) | Option Ex | 22,725 | 69.34 | 1,575,751 |
| 2014-02-24 | Whitfield Roy A (Director) | Sale | 2,000 | 175.26 | 350,520 |
| 2014-02-24 | Whitfield Roy A (Director) | Option Ex | 2,000 | 19.61 | 39,220 |
| 2014-02-18 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 2,000 | 169.82 | 339,636 |
| 2014-02-18 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 2,000 | 43.37 | 86,740 |
| 2014-02-18 | Henry Christian O (SVP, Chief Commercial Officer) | Sale | 6,000 | 170.16 | 1,020,983 |
| 2014-02-18 | Henry Christian O (SVP, Chief Commercial Officer) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2014-02-13 | Flatley Jay T (CEO) | Sale | 30,000 | 160.68 | 4,820,460 |
| 2014-02-13 | Flatley Jay T (CEO) | Option Ex | 30,000 | 20.04 | 601,200 |
| 2014-02-07 | Flatley Jay T (CEO) | Sale | 5,000 | 152.23 | 761,135 |
| 2014-02-03 | Bianchi Paul L (Sr VP, Human Resources) | Sale | 663 | 151.53 | 100,464 |
| 2014-02-03 | Rastetter William H (Director) | Sale | 8,551 | 152.28 | 1,302,171 |
| 2014-01-31 | Stapley Marc (Sr VP & CFO) | Sale | 20,038 | 150.77 | 3,021,169 |
| 2014-01-31 | Stapley Marc (Sr VP & CFO) | Option Ex | 17,064 | 36.30 | 619,423 |
| 2014-01-28 | Henry Christian O (SVP, Chief Commercial Officer) | Sale | 6,000 | 142.40 | 854,394 |
| 2014-01-28 | Henry Christian O (SVP, Chief Commercial Officer) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2014-01-23 | Flatley Jay T (CEO) | Sale | 30,000 | 142.58 | 4,277,490 |
| 2014-01-23 | Flatley Jay T (CEO) | Option Ex | 30,000 | 15.26 | 457,890 |
| 2014-01-16 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 6,000 | 124.64 | 747,864 |
| 2014-01-16 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2014-01-15 | Naclerio Nicholas (SVP Corp & Venture Development) | Sale | 2,000 | 122.39 | 244,790 |
| 2014-01-15 | Naclerio Nicholas (SVP Corp & Venture Development) | Option Ex | 2,000 | 43.37 | 86,740 |
| 2014-01-09 | Flatley Jay T (CEO) | Sale | 30,000 | 115.10 | 3,453,060 |
| 2014-01-09 | Flatley Jay T (CEO) | Option Ex | 30,000 | 10.48 | 314,550 |
| 2014-01-02 | Eastham Karin (Director) | Sale | 10,000 | 109.76 | 1,097,560 |
| 2014-01-02 | Eastham Karin (Director) | Option Ex | 10,000 | 39.14 | 391,400 |
| 2013-12-26 | Flatley Jay T (CEO) | Sale | 30,000 | 107.88 | 3,236,310 |
| 2013-12-26 | Flatley Jay T (CEO) | Option Ex | 30,000 | 10.48 | 314,550 |
| 2013-12-17 | Heath Gregory (Sr VP & General Manager) | Sale | 1,875 | 102.68 | 192,525 |
| 2013-12-17 | Heath Gregory (Sr VP & General Manager) | Option Ex | 1,875 | 53.19 | 99,731 |
| 2013-12-16 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 2,000 | 102.76 | 205,528 |
| 2013-12-16 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 2,000 | 43.37 | 86,740 |
| 2013-12-12 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 6,000 | 100.44 | 602,640 |
| 2013-12-12 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2013-12-12 | Flatley Jay T (President & CEO) | Sale | 30,000 | 100.23 | 3,006,900 |
| 2013-12-12 | Flatley Jay T (President & CEO) | Option Ex | 30,000 | 10.48 | 314,550 |
| 2013-12-02 | Bouchard Michel (VP, Finance) | Sale | 788 | 97.87 | 77,121 |
| 2013-12-02 | Bouchard Michel (VP, Finance) | Option Ex | 788 | 37.04 | 29,187 |
| 2013-11-29 | Flatley Jay T (President & CEO) | Sale | 30,000 | 98.52 | 2,955,600 |
| 2013-11-29 | Flatley Jay T (President & CEO) | Option Ex | 30,000 | 10.48 | 314,550 |
| 2013-11-27 | Walt David R (Director) | Sale | 5,000 | 99.33 | 496,644 |
| 2013-11-25 | Whitfield Roy A (Director) | Sale | 2,000 | 100.00 | 200,000 |
| 2013-11-25 | Whitfield Roy A (Director) | Option Ex | 2,000 | 19.61 | 39,220 |
| 2013-11-21 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 6,000 | 95.01 | 570,084 |
| 2013-11-21 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2013-11-18 | Heath Gregory (Sr VP & General Manager) | Sale | 1,875 | 93.53 | 175,368 |
| 2013-11-18 | Heath Gregory (Sr VP & General Manager) | Option Ex | 1,875 | 53.19 | 99,731 |
| 2013-11-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 2,000 | 93.21 | 186,420 |
| 2013-11-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 2,000 | 43.37 | 86,740 |
| 2013-11-13 | Walt David R (Director) | Sale | 5,000 | 95.48 | 477,380 |
| 2013-11-01 | Lewis Mark L (Sr VP & General Manager) | Sale | 5,000 | 94.50 | 472,480 |
| 2013-11-01 | Lewis Mark L (Sr VP & General Manager) | Option Ex | 5,000 | 37.04 | 185,200 |
| 2013-11-01 | Eastham Karin (Director) | Sale | 10,000 | 94.80 | 947,980 |
| 2013-11-01 | Eastham Karin (Director) | Option Ex | 10,000 | 17.57 | 175,750 |
| 2013-10-31 | Bouchard Michel (VP, Finance) | Sale | 787 | 93.14 | 73,301 |
| 2013-10-31 | Bouchard Michel (VP, Finance) | Option Ex | 787 | 37.04 | 29,150 |
| 2013-10-30 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 6,000 | 93.55 | 561,306 |
| 2013-10-30 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2013-10-30 | Walt David R (Director) | Sale | 5,000 | 93.38 | 466,915 |
| 2013-10-28 | Rastetter William H (Director) | Sale | 20,000 | 92.59 | 1,851,800 |
| 2013-10-28 | Rastetter William H (Director) | Option Ex | 20,000 | 3.24 | 64,800 |
| 2013-10-24 | Flatley Jay T (President & CEO) | Sale | 30,000 | 92.27 | 2,768,010 |
| 2013-10-24 | Flatley Jay T (President & CEO) | Option Ex | 30,000 | 10.48 | 314,550 |
| 2013-10-22 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 20,000 | 90.00 | 1,800,000 |
| 2013-10-22 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 20,000 | 69.34 | 1,386,800 |
| 2013-10-17 | Heath Gregory (Sr VP & General Manager) | Sale | 1,875 | 82.09 | 153,918 |
| 2013-10-17 | Heath Gregory (Sr VP & General Manager) | Option Ex | 1,875 | 53.19 | 99,731 |
| 2013-10-16 | Walt David R (Director) | Sale | 5,000 | 82.91 | 414,560 |
| 2013-10-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 4,000 | 81.32 | 325,264 |
| 2013-10-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 4,000 | 43.37 | 173,480 |
| 2013-10-10 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 6,000 | 77.51 | 465,042 |
| 2013-10-10 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2013-10-10 | Flatley Jay T (President & CEO) | Sale | 20,000 | 77.73 | 1,554,600 |
| 2013-10-10 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
| 2013-10-02 | Walt David R (Director) | Sale | 5,000 | 80.58 | 402,885 |
| 2013-10-01 | Bouchard Michel (VP, Finance) | Sale | 788 | 81.05 | 63,867 |
| 2013-10-01 | Bouchard Michel (VP, Finance) | Option Ex | 788 | 37.04 | 29,187 |
| 2013-09-26 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 6,000 | 81.34 | 488,027 |
| 2013-09-26 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 6,000 | 28.45 | 170,700 |
| 2013-09-26 | Flatley Jay T (President & CEO) | Sale | 20,000 | 81.34 | 1,626,740 |
| 2013-09-26 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
| 2013-09-18 | Walt David R (Director) | Sale | 5,000 | 83.33 | 416,665 |
| 2013-09-17 | Heath Gregory (Sr VP & General Manager) | Sale | 1,875 | 85.20 | 159,750 |
| 2013-09-17 | Heath Gregory (Sr VP & General Manager) | Option Ex | 1,875 | 53.19 | 99,731 |
| 2013-09-16 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 4,000 | 85.00 | 340,000 |
| 2013-09-16 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 4,000 | 43.37 | 173,480 |
| 2013-09-16 | Flatley Jay T (President & CEO) | Sale | 10,000 | 85.00 | 850,000 |
| 2013-09-16 | Flatley Jay T (President & CEO) | Option Ex | 10,000 | 10.48 | 104,850 |
| 2013-09-12 | Flatley Jay T (President & CEO) | Sale | 20,000 | 82.64 | 1,652,880 |
| 2013-09-12 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
| 2013-09-10 | Heath Gregory (Sr VP & General Manager) | Sale | 1,875 | 82.00 | 153,750 |
| 2013-09-10 | Heath Gregory (Sr VP & General Manager) | Option Ex | 1,875 | 53.19 | 99,731 |
| 2013-09-09 | Bianchi Paul L (Sr VP, Human Resources) | Sale | 1,627 | 79.03 | 128,581 |
| 2013-09-05 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 9,000 | 78.13 | 703,161 |
| 2013-09-05 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 9,000 | 30.47 | 274,212 |
| 2013-09-04 | Walt David R (Director) | Sale | 5,000 | 77.19 | 385,955 |
| 2013-09-03 | Bouchard Michel (VP, Finance) | Sale | 787 | 78.49 | 61,771 |
| 2013-09-03 | Bouchard Michel (VP, Finance) | Option Ex | 787 | 37.04 | 29,150 |
| 2013-09-03 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 59,000 | 77.79 | 4,589,787 |
| 2013-09-03 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 59,000 | 43.37 | 2,558,830 |
| 2013-09-03 | Whitfield Roy A (Director) | Sale | 2,000 | 78.49 | 156,980 |
| 2013-09-03 | Whitfield Roy A (Director) | Option Ex | 2,000 | 19.61 | 39,220 |
| 2013-08-30 | Lewis Mark L (Sr VP & General Manager) | Sale | 5,000 | 78.12 | 390,590 |
| 2013-08-30 | Lewis Mark L (Sr VP & General Manager) | Option Ex | 5,000 | 37.04 | 185,200 |
| 2013-08-22 | Flatley Jay T (President & CEO) | Sale | 20,000 | 78.65 | 1,573,020 |
| 2013-08-22 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
| 2013-08-21 | Walt David R (Director) | Sale | 5,000 | 78.34 | 391,715 |
| 2013-08-15 | Naclerio Nicholas (SVP Corporate Development) | Sale | 2,000 | 78.43 | 156,860 |
| 2013-08-15 | Naclerio Nicholas (SVP Corporate Development) | Option Ex | 2,000 | 43.37 | 86,740 |
| 2013-08-15 | Henry Christian O (SVP/GM Genomic Solutions) | Sale | 9,000 | 78.23 | 704,043 |
| 2013-08-15 | Henry Christian O (SVP/GM Genomic Solutions) | Option Ex | 9,000 | 30.47 | 274,212 |
| 2013-08-08 | Flatley Jay T (President & CEO) | Sale | 20,000 | 78.29 | 1,565,880 |
| 2013-08-08 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
| 2013-08-07 | Walt David R (Director) | Sale | 5,000 | 78.47 | 392,360 |
| 2013-08-02 | Bouchard Michel (VP, Finance) | Sale | 151 | 79.94 | 12,070 |
| 2013-07-31 | Bouchard Michel (VP, Finance) | Sale | 11,314 | 80.64 | 912,406 |
| 2013-07-31 | Bouchard Michel (VP, Finance) | Option Ex | 11,314 | 37.04 | 419,070 |
| 2013-07-25 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 11,462 | 80.89 | 927,172 |
| 2013-07-25 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 6,000 | 30.47 | 182,808 |
| 2013-07-25 | Flatley Jay T (President & CEO) | Sale | 20,000 | 81.30 | 1,625,920 |
| 2013-07-25 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
| 2013-07-24 | Bouchard Michel (VP, Finance) | Sale | 9,789 | 79.28 | 776,042 |
| 2013-07-24 | Bouchard Michel (VP, Finance) | Option Ex | 9,789 | 37.16 | 363,808 |
| 2013-07-24 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 20,000 | 80.00 | 1,600,000 |
| 2013-07-24 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 20,000 | 43.37 | 867,400 |
| 2013-07-24 | Heath Gregory (Sr VP & General Manager) | Sale | 209,533 | 82.00 | 17,181,706 |
| 2013-07-24 | Heath Gregory (Sr VP & General Manager) | Option Ex | 209,533 | 41.89 | 8,777,756 |
| 2013-07-24 | Walt David R (Director) | Sale | 4,600 | 81.47 | 374,785 |
| 2013-07-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 2,000 | 74.50 | 149,000 |
| 2013-07-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 2,000 | 43.37 | 86,740 |
| 2013-07-11 | Ronaghi Mostafa (Sr VP & CTO) | Sale | 24,000 | 75.00 | 1,799,976 |
| 2013-07-11 | Ronaghi Mostafa (Sr VP & CTO) | Option Ex | 24,000 | 36.62 | 878,951 |
| 2013-07-11 | Flatley Jay T (President & CEO) | Sale | 20,000 | 74.90 | 1,497,980 |
| 2013-07-11 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
| 2013-07-10 | Bouchard Michel (VP, Finance) | Sale | 3,618 | 74.30 | 268,824 |
| 2013-07-10 | Bouchard Michel (VP, Finance) | Option Ex | 3,618 | 37.10 | 134,235 |
| 2013-07-10 | Walt David R (Director) | Sale | 5,000 | 74.26 | 371,300 |
| 2013-07-09 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 9,000 | 74.01 | 666,054 |
| 2013-07-09 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 9,000 | 30.47 | 274,212 |
Insider trading activities including stock purchases, stock sales, and option exercises of ILMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Illumina, Inc. (symbol ILMN, CIK number 1110803) see the Securities and Exchange Commission (SEC) website.